Category: Advocacy news
EHA in the BioMed Alliance: joining forces for biomedical research
EHA is an active member of the Alliance for Biomedical Research in Europe (BioMed Alliance), in which Europe’s leading medical societies have joined forces to represent the interests of over 400,000 researchers and health professionals.
European Reference Networks, a unique opportunity to take collaboration and pati...
On Saturday 11 June, a session in the Patient Advocacy Track focused on the emerging European Reference Networks (ERNs).
PRESS RELEASE: The future of research in hematology is here
The Hague, January 27, 2016 In the February 2016 issue of Haematologica, critical research of blood and blood-forming organs in Europe is given a boost. The European Hematology Association Roadmap for European Hematology Research: A Consensus Document summarizes the current status of basic, translational and clinical hematology research and identifies areas of unmet scientific and medical need in Europe. It provides guidance for European and national policy makers, funding agencies, charities, research institutes and researchers when they make decisions on initiating or funding research and developing research programs.
A European Reference Network for Rare Hematological Diseases
You may have heard of European Reference Networks (ERNs). But most likely you have not because they do not exist yet. ERNs are networks of specialized hospital departments and research centers to treat rare or low-prevalent complex diseases and they are foreseen to be established by the end of this year. EHA wants to support the establishment of an ERN for Rare Hematological Diseases.
Survey Monitoring H2020 – your input is needed!
We need your input to improve Horizon 2020 and the next Research and Innovation Framework Programme of the European Union.
IMI2 Call for Research Proposals
On October 6, 2015, the Innovative Medicines Initiative (IMI) launched its 6th Call for proposals under IMI 2. This call includes, under the program “Big Data for Better Outcomes programme”, the topic:
Development of an outcomes-focused platform to empower policy makers and clinicians to optimize care for patients with hematologic malignancies.
The European Union must deliver funding for research of blood disorders
At the Congress of the European Hematology Association (EHA) – attracting 10,000 hematologists from Europe and beyond - the president of EHA, Prof. Christine Chomienne, called upon the European Union to deliver funding for Research into Blood Disorders:
“The hematologists in Europe have done a great work. Now it’s the EU’s turn to deliver.”
Training vital for new era of patient-centric healthcare
By European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan (Source: EU Reporter Correspondent | June 5, 2015)
First Horizon 2020 Work Programme update – budget, and launch of FTI and innovat...
On July 22, the European Commission announced an update of the Work Programme 2014-2015. Hematologists should be aware that in 2015 opportunities are available to them in the Societal Challenge Health, demographic change and wellbeing.
The importance of education and collaboration for the treatment of patients
Today, EU Reporter published an article by Ulrich Jäger, past president of the European Hematology Association (EHA) and chair of the European Affairs Committee, highlighting the importance of education and collaboration for the treatment of patients.
Major research funding calls are out now
In the course of one day – December 11, 2013 – two calls for applications and expressions of interest were published that are of interest to researchers in hematology.
The International Society on Thrombosis and Haemostasis (ISTH) Hosts its Second ...
CASCAIS, PORTUGAL: The ISTH is hosting its Second Annual Advanced Training Course on Thrombosis and Haemostasis on March 13-16, 2014, at the Hotel Quinta da Marinha in Cascais, Portugal. As part of the Society’s mission, the course will provide the latest training in the treatment of thrombosis and bleeding disorder management to meet the needs of hematologists and related specialists around the world. Space is limited to only 200 participants; early registration is recommended to ensure availability.
The meeting will provide three full days of intense examination on the subjects of blood coagulation and bleeding disorders, platelets and venous thrombosis. Leading scientists with vast experience in education will deliver focused lectures followed by ample time for discussion and close interaction with the participants. Meet the Expert sessions will be devoted to discussion groups with the day’s speakers. There will also be interactive sessions in the evening with exercises relating to the analysis of the topics discussed during the day or on clinical case studies. A formal program is available here.
Research must provide ‘more good news on outcomes’ while patients need simple an...
Hematology is one of few medical disciplines that have made significant steps in realizing the promise of personalized medicine. Together with ESMO and Eurocan Platform and in the context of our membership of the European Alliance for Personalised Medicine (EAPM), EHA was involved in the organization of a Roundtable ‘Oncology/Haematology: How to provide the right prevention and treatment to the right patient at the right time’.
Position of EHA on Access to Medicines
Access to medicines is a fundamental element of the human right to health. While recognizing the need to keep our health systems affordable, we see great danger in hematologists having to prioritize patients, substitute standard for improvised regimens or choose unproven treatment options. As part of our mission to promote excellence in clinical practice in hematology we call upon the EU to promote knowledge building, increase transparency and take evidence-based measures that remove unnecessary barriers to patient access to medicines in Europe.
Position of EHA on the Harmonization of Training and Education in Europe
Trainees and specialists in hematology must be fit for practice. It is our mission to promote excellence in education in European hematology. To improve patient care and public health it is essential to raise and maintain the skills and competences of hematologists to an equally high standard across European countries. Therefore, we aim to harmonize and improve training and education in hematology in Europe.